US Stocks
/
Krystal Biotech, Inc. Share Price

Krystal Biotech, Inc. Share Price

NASDAQ: KRYS | Mid Cap
$331.81
+$4.21 (1.29%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Krystal Biotech, Inc. Stock Performance

Open
$328.55
Prev. Close
$327.60
Circuit Range
N/A
Day Range
$324.01 - $333.29
Year Range
$180.74 - $382.01
Volume
11,607
Average Traded
$330.44

Krystal Biotech, Inc. Share Price Today

As of 10 October 2026, Krystal Biotech, Inc.'s share price is $331.81. The stock opened at $328.55, compared to its previous close of $327.60. During today's trading session, Krystal Biotech, Inc.'s share price traded between $324.01 and $333.29, with an average price of $328.65. Over the past 52 weeks, the stock has recorded a high of $382.01 and a low of $180.74. In terms of performance, Krystal Biotech, Inc.'s share price has risen by 26.44% over the last six months and is up 68.38% on a year-on-year basis.

Krystal Biotech, Inc. Share Price Chart

$324.01$333.29
L
Show Current Price
H

Krystal Biotech, Inc. Stock Fundamentals & Key Indicators

Market Cap
$9.60B
PE Ratio (TTM)
40.12
Dividend Yield
0.00%
EPS (TTM)
$8.16
Revenue (TTM)
$389.13B
Return On Equity (TTM)
17.77%
Profit Margin
52.64%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-30.99%

Krystal Biotech, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$97.80$107.11$116.36$119.22
Net Profit$79.37$51.40$55.93$54.77
Net Profit Margin81.16%47.99%48.07%45.94%
Income ChangeN/A-35.24%8.81%-2.07%

Krystal Biotech, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$50.70$290.52$389.13
Net Profit-$139.98$10.93$89.16$204.83
Net Profit MarginN/A21.56%30.69%52.64%
Income ChangeN/A107.81%715.74%129.73%

About Krystal Biotech, Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Krystal Biotech, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$330.56
$331.55
-0.55%
Sep 2026
$360.80
$333.38
-6.74%
Aug 2026
$322.00
$357.49
+4.81%
Jul 2026
$369.77
$341.08
-8.25%
Jun 2026
$306.16
$371.74
+20.25%
May 2026
$263.03
$309.14
+17.80%
Apr 2026
$258.50
$262.42
+1.79%
Mar 2026
$267.50
$257.81
-6.37%
Feb 2026
$279.99
$275.35
-1.38%
Jan 2026
$245.06
$279.19
+12.87%
Dec 2025
$213.98
$247.35
+13.87%
Nov 2025
$196.15
$217.22
+10.23%

KRYS Share Price FAQs

What is Krystal Biotech, Inc. share price today?

chevron-up
Krystal Biotech, Inc. share price today is $331.81 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Krystal Biotech, Inc. stock?

chevron-up
The 52 week high of Krystal Biotech, Inc. stock is $382.01, while the 52 week low is $180.74 as of 10 Oct '26.

What is KRYS's market capitalisation today?

chevron-up
KRYS market capitalisation is $9.60B as of October 10, 2026, at 4:41 am IST.

What is KRYS's net income for the last quarter?

chevron-up
KRYS's net income for the last quarter is 54.77B USD.

What is the 5 year returns of KRYS?

chevron-up
The 5 year returns of KRYS is 562.43% as on 10 Oct '26.

What is the high & low stock price of KRYS today?

chevron-up
KRYS stock price hit a high of $333.29 and low of $324.01 as of 10 Oct '26.

Can I buy KRYS shares in India?

chevron-up
Yes. You can buy KRYS in India by opening an international trading account.